AIDS Vaccines: The Next Frontiers
Key points
- The AIDS Vaccine Advocacy Coalition on Thursday released its annual report, titled "AIDS Vaccines: The Next Frontiers," which says that without sufficient future planning, AIDS vaccine research could be slowed.
- The report - which lists critical steps to ensure that goals in HIV/AIDS prevention technologies, including AIDS vaccines, are met - summarizes issues and challenges in developing HIV/AIDS prevention technologies.
- "Planning for different scenarios for AIDS prevention at this stage is essential," Mitchell Warren, executive director of AVAC, said, adding, "Without adequate planning and coordination, the issues which will emerge as one or more interventions show signs of some efficacy could slow the pace of future studies.
- And we must simultaneously lay the groundwork now to ensure new prevention methods reach the people who need them most."
The AIDS Vaccine Advocacy Coalition on Thursday released its annual report, titled "AIDS Vaccines: The Next Frontiers," which says that without sufficient future planning, AIDS vaccine research could be slowed.
The report - which lists critical steps to ensure that goals in HIV/AIDS prevention technologies, including AIDS vaccines, are met - summarizes issues and challenges in developing HIV/AIDS prevention technologies.
"Planning for different scenarios for AIDS prevention at this stage is essential," Mitchell Warren, executive director of AVAC, said, adding, "Without adequate planning and coordination, the issues which will emerge as one or more interventions show signs of some efficacy could slow the pace of future studies.
And we must simultaneously lay the groundwork now to ensure new prevention methods reach the people who need them most."
The report includes an update on AIDS vaccine science and funding; an analysis of successes and challenges in the search for an AIDS vaccine; a look into how the licensing and distribution of the HPV vaccine can inform future AIDS vaccine initiatives; and an outline of future challenges in AIDS vaccine developments (AVAC release, 9/14).
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsStudies in monkeys may be next step in search for HIV cure
A powerful infusion of HIV-fighting antibodies beat back a potent form of the virus in monkeys and kept it at bay for weeks, U.S. government scientists and a team led by Harvard University found, offering a potential…
1 November 2013
NewsHIV - Geneticists map human resistance to AIDS
Do our genes hold the key to future AIDS therapies? Using a supercomputer, scientists analyzed the genomes of thousands of strains of the HIV virus and have produced the first map of human AIDS resistance The key to…
29 October 2013
NewsTo halt AIDS, stop brief risk counseling, concentrate on testing, national study says
For decades, people seeking an HIV test have been counseled on realistic and achievable steps they could take to avoid infection. But a national study led by Miller School investigators has determined that, given the…
